Mark Lesney - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Mark Lesney's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Mark Lesney
Verified
Managing Editor, MDedge Hematology and Oncology
Washington
Beats
General assignment
Content
By Mark Lesney Verified| Medscape Verified closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log outCancel News > Medscape Medical News > Conference News This year's World Bronchiectasis and NTM Conference will be held in New York from July 18–20.
By Mark Lesney Verified| MDEdge Verified Sepsis survivors discharged to post-acute care facilities are at high risk for mortality and hospital readmission, according to Nicholas Colucciello, MD, and few interventions have been shown to reduce these adverse outcomes. Dr. Colucciello and colleagues compared the effects of a Sepsis Transition And Recovery (STAR) program versus Usual Care (UC) alone on 30-day mortality and hospital readmission among sepsis survivors discharged to post-acute care.
By Mark Lesney Verified| Medscape Verified closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log outCancel News > Medscape Medical News > Conference News This year's World Bronchiectasis and NTM Conference will be held in New York from July 18–20.
Company Info
MDedge Hematology and Oncology
Parsippany-Troy Hills, New Jersey, United States
+1 240-221-2468